A Better Health Primary Care Pllc - Medicare Primary Care in Biloxi, MS

A Better Health Primary Care Pllc is a medicare enrolled primary clinic (Family Medicine) in Biloxi, Mississippi. The current practice location for A Better Health Primary Care Pllc is 971 Tommy Munro Dr Ste D, Biloxi, Mississippi. For appointments, you can reach them via phone at (662) 809-4458. The mailing address for A Better Health Primary Care Pllc is 971 Tommy Munro Dr Ste D, Biloxi, Mississippi and phone number is (228) 207-1777.

A Better Health Primary Care Pllc is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1881478188. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (662) 809-4458.

Contact Information

A Better Health Primary Care Pllc
971 Tommy Munro Dr Ste D
Biloxi
MS 39532-2137
(662) 809-4458
(619) 326-3977

Primary Care Clinic Profile

Full NameA Better Health Primary Care Pllc
SpecialityFamily Medicine
Location971 Tommy Munro Dr Ste D, Biloxi, Mississippi
Authorized Official Name and PositionMolly B Brown (OWNER)
Authorized Official Contact2820717772
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
A Better Health Primary Care Pllc
971 Tommy Munro Dr Ste D
Biloxi
MS 39532-2137

Ph: (228) 207-1777
A Better Health Primary Care Pllc
971 Tommy Munro Dr Ste D
Biloxi
MS 39532-2137

Ph: (662) 809-4458

NPI Details:

NPI Number1881478188
Provider Enumeration Date08/21/2023
Last Update Date01/04/2024

Medicare PECOS Information:

Medicare PECOS PAC ID3678927506
Medicare Enrollment IDO20230927000682

News Archive

XRCC2 gene mutations cause increased breast cancer risk

Mutations in a gene called XRCC2 cause increased breast cancer risk, according to a study published today in the American Journal of Human Genetics. The study looked at families that have a history of the disease but do not have mutations in the currently known breast cancer susceptibility genes.

Continued rise of PSA value in prostate cancer patients can indicate relapsing disease

Prostate cancer patients who have a prostate-specific antigen (PSA) value of less than or equal to 1.5 at two years after external beam radiation therapy (EBRT) are less likely to have a cancer recurrence and cancer-related death, according to a study in the December 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

NCA awards over $10M for development and implementation of multi-disciplinary approach to child abuse

On January 13th, 2010, National Children's Alliance (NCA), under agreement with the United States Department of Justice Office of Juvenile Justice and Delinquency Prevention (OJJDP), announced grant awards over $10 million distributed among 539 Child Advocacy Centers and Multi-Disciplinary Teams across the country.

Cadence Pharmaceuticals to acquire Incline Therapeutics

Cadence Pharmaceuticals, Inc., a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that it has signed an agreement providing Cadence with an exclusive option to acquire Incline Therapeutics, Inc., a privately held specialty pharmaceutical company.

Preliminary research findings from Kessler Foundation's Ekso device study on SCI

Kessler Foundation has released preliminary research findings from its clinical study of the wearable robotic exoskeletal device, Ekso. Gail Forrest, PhD, assistant director of Human Performance and Engineering Research, presented the Ekso research data on September 3, at the meeting of the Academy of Spinal Cord Injury Professionals at the Rio Suites in Las Vegas. Dr. Forrest directs mobility research at the Foundation, including activity-based locomotor therapy, functional electrical stimulation, and treadmill training with the LokomatPro v6, as well as Ekso.

Read more Medical News

› Verified 6 days ago

Medical Identifiers

Medical identifiers for A Better Health Primary Care Pllc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1881478188NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. A Better Health Primary Care Pllc acts as a billing entity for following providers:
Provider NameMolly B Brown
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1033464508
PECOS PAC ID: 8527204965
Enrollment ID: I20130409000587

News Archive

XRCC2 gene mutations cause increased breast cancer risk

Mutations in a gene called XRCC2 cause increased breast cancer risk, according to a study published today in the American Journal of Human Genetics. The study looked at families that have a history of the disease but do not have mutations in the currently known breast cancer susceptibility genes.

Continued rise of PSA value in prostate cancer patients can indicate relapsing disease

Prostate cancer patients who have a prostate-specific antigen (PSA) value of less than or equal to 1.5 at two years after external beam radiation therapy (EBRT) are less likely to have a cancer recurrence and cancer-related death, according to a study in the December 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

NCA awards over $10M for development and implementation of multi-disciplinary approach to child abuse

On January 13th, 2010, National Children's Alliance (NCA), under agreement with the United States Department of Justice Office of Juvenile Justice and Delinquency Prevention (OJJDP), announced grant awards over $10 million distributed among 539 Child Advocacy Centers and Multi-Disciplinary Teams across the country.

Cadence Pharmaceuticals to acquire Incline Therapeutics

Cadence Pharmaceuticals, Inc., a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that it has signed an agreement providing Cadence with an exclusive option to acquire Incline Therapeutics, Inc., a privately held specialty pharmaceutical company.

Preliminary research findings from Kessler Foundation's Ekso device study on SCI

Kessler Foundation has released preliminary research findings from its clinical study of the wearable robotic exoskeletal device, Ekso. Gail Forrest, PhD, assistant director of Human Performance and Engineering Research, presented the Ekso research data on September 3, at the meeting of the Academy of Spinal Cord Injury Professionals at the Rio Suites in Las Vegas. Dr. Forrest directs mobility research at the Foundation, including activity-based locomotor therapy, functional electrical stimulation, and treadmill training with the LokomatPro v6, as well as Ekso.

Read more Medical News

› Verified 6 days ago

Provider NameDeborah Ann Fore
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1962286344
PECOS PAC ID: 7618329020
Enrollment ID: I20240122003406

News Archive

XRCC2 gene mutations cause increased breast cancer risk

Mutations in a gene called XRCC2 cause increased breast cancer risk, according to a study published today in the American Journal of Human Genetics. The study looked at families that have a history of the disease but do not have mutations in the currently known breast cancer susceptibility genes.

Continued rise of PSA value in prostate cancer patients can indicate relapsing disease

Prostate cancer patients who have a prostate-specific antigen (PSA) value of less than or equal to 1.5 at two years after external beam radiation therapy (EBRT) are less likely to have a cancer recurrence and cancer-related death, according to a study in the December 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

NCA awards over $10M for development and implementation of multi-disciplinary approach to child abuse

On January 13th, 2010, National Children's Alliance (NCA), under agreement with the United States Department of Justice Office of Juvenile Justice and Delinquency Prevention (OJJDP), announced grant awards over $10 million distributed among 539 Child Advocacy Centers and Multi-Disciplinary Teams across the country.

Cadence Pharmaceuticals to acquire Incline Therapeutics

Cadence Pharmaceuticals, Inc., a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that it has signed an agreement providing Cadence with an exclusive option to acquire Incline Therapeutics, Inc., a privately held specialty pharmaceutical company.

Preliminary research findings from Kessler Foundation's Ekso device study on SCI

Kessler Foundation has released preliminary research findings from its clinical study of the wearable robotic exoskeletal device, Ekso. Gail Forrest, PhD, assistant director of Human Performance and Engineering Research, presented the Ekso research data on September 3, at the meeting of the Academy of Spinal Cord Injury Professionals at the Rio Suites in Las Vegas. Dr. Forrest directs mobility research at the Foundation, including activity-based locomotor therapy, functional electrical stimulation, and treadmill training with the LokomatPro v6, as well as Ekso.

Read more Medical News

› Verified 6 days ago

News Archive

XRCC2 gene mutations cause increased breast cancer risk

Mutations in a gene called XRCC2 cause increased breast cancer risk, according to a study published today in the American Journal of Human Genetics. The study looked at families that have a history of the disease but do not have mutations in the currently known breast cancer susceptibility genes.

Continued rise of PSA value in prostate cancer patients can indicate relapsing disease

Prostate cancer patients who have a prostate-specific antigen (PSA) value of less than or equal to 1.5 at two years after external beam radiation therapy (EBRT) are less likely to have a cancer recurrence and cancer-related death, according to a study in the December 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

NCA awards over $10M for development and implementation of multi-disciplinary approach to child abuse

On January 13th, 2010, National Children's Alliance (NCA), under agreement with the United States Department of Justice Office of Juvenile Justice and Delinquency Prevention (OJJDP), announced grant awards over $10 million distributed among 539 Child Advocacy Centers and Multi-Disciplinary Teams across the country.

Cadence Pharmaceuticals to acquire Incline Therapeutics

Cadence Pharmaceuticals, Inc., a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that it has signed an agreement providing Cadence with an exclusive option to acquire Incline Therapeutics, Inc., a privately held specialty pharmaceutical company.

Preliminary research findings from Kessler Foundation's Ekso device study on SCI

Kessler Foundation has released preliminary research findings from its clinical study of the wearable robotic exoskeletal device, Ekso. Gail Forrest, PhD, assistant director of Human Performance and Engineering Research, presented the Ekso research data on September 3, at the meeting of the Academy of Spinal Cord Injury Professionals at the Rio Suites in Las Vegas. Dr. Forrest directs mobility research at the Foundation, including activity-based locomotor therapy, functional electrical stimulation, and treadmill training with the LokomatPro v6, as well as Ekso.

Read more News

› Verified 6 days ago


Family Medicine in Biloxi, MS

Pass Road Walk-in Clinic
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2771 Pass Rd, Suite B, Biloxi, MS 39531
Phone: 228-385-4645    Fax: 228-385-4695
Healthstop Llc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2490 Pass Rd, Biloxi, MS 39531
Phone: 228-207-9967    Fax: 228-273-1532
Khaled A Rikabi, Md
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 180 Debuys Rd., 215, Biloxi, MS 39531
Phone: 228-594-6484    Fax: 228-594-6494
Regional Digestive Specialists, P.c.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 15012 Lemoyne Blvd, Biloxi, MS 39532
Phone: 228-392-5787    Fax: 228-354-9169
Ochsner Mississippi, Llc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2781 C T Switzer Sr Dr Ste 302, Biloxi, MS 39531
Phone: 228-388-4816    Fax: 228-388-5906
Painstop Spine Clinic, Llc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 180 Debuys Rd, Biloxi, MS 39531
Phone: 228-273-4096    Fax: 228-594-1765
Medical Analysis Llc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1025 Division St, Biloxi, MS 39530
Phone: 228-388-2599    Fax: 228-388-4157

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.